BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 33230826)

  • 1. National data on the early clinical use of non-invasive prenatal testing in public and private healthcare in Denmark 2013-2017.
    Lund ICB; Petersen OB; Becher NH; Lildballe DL; Jørgensen FS; Ambye L; Skibsted L; Ernst A; Jensen AN; Fagerberg C; Brasch-Andersen C; Tabor A; Zingenberg HJ; Nørgaard P; Almind GJ; Vestergaard EM; Vogel I
    Acta Obstet Gynecol Scand; 2021 May; 100(5):884-892. PubMed ID: 33230826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective clinical evaluation of Momguard non-invasive prenatal test in 1011 Korean high-risk pregnant women.
    Hu HJ; Lee MY; Cho DY; Oh M; Kwon YJ; Han YJ; Ryu HM; Kim YN; Won HS
    J Obstet Gynaecol; 2020 Nov; 40(8):1090-1095. PubMed ID: 31826681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenomic results following high-chance non-invasive prenatal testing: a UK national audit.
    Togneri FS; Allen SK; Mann K; Holgado E; Morgan S
    Genet Res (Camb); 2020 Sep; 102():e7. PubMed ID: 32867862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
    Junhui W; Ru L; Qiuxia Y; Dan W; Xiuhong S; Yongling Z; Xiangyi J; Fatao L; Xuewei T; Guilan C; Fan J; Fucheng L; Fang F; Yan L; Lina Z; Cuixing Y; Jian L; Dongzhi L; Can L
    Prenat Diagn; 2021 May; 41(6):690-696. PubMed ID: 33480032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance and Diagnostic Value of Genome-Wide Noninvasive Prenatal Testing in Multiple Gestations.
    van Riel M; Brison N; Baetens M; Blaumeiser B; Boemer F; Bourlard L; Bulk S; De Leener A; Désir J; Devriendt K; Dheedene A; Duquenne A; Fieremans N; Fieuw A; Gatot JS; Grisart B; Janssens S; Khudashvili N; Lannoo L; Marichal A; Meunier C; Palmeira L; Parijs I; Pichon B; Roets E; Sammels E; Smits G; Suenaert M; Sznajer Y; Van den Bogaert K; Vancoillie L; Vandeputte L; Vantroys E; Vermeesch JR; Janssens K
    Obstet Gynecol; 2021 Jun; 137(6):1102-1108. PubMed ID: 33957658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England.
    Sacco A; Hewitt H; Pandya P
    Arch Dis Child; 2020 Jan; 105(1):47-52. PubMed ID: 31243005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
    van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
    Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.
    Lee DE; Kim H; Park J; Yun T; Park DY; Kim M; Ryu HM
    J Korean Med Sci; 2019 Jun; 34(24):e172. PubMed ID: 31222985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance of non-invasive prenatal testing for trisomies 21, 18 and 13 in twin pregnancies: A cohort study and a systematic meta-analysis.
    He Y; Wang Y; Li Z; Chen H; Deng J; Huang H; He X; Zeng W; Liu M; Huang B; Chen P
    Acta Obstet Gynecol Scand; 2020 Jun; 99(6):731-743. PubMed ID: 32166736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on non-invasive prenatal screening for the detection of aneuploidy.
    Chen Y; Yang F; Shang X; Liu S; Li M; Zhong M
    Ginekol Pol; 2022; 93(9):716-720. PubMed ID: 35315016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Invasive Prenatal Testing (NIPT) in pregnancies with trisomy 21, 18 and 13 performed in a public setting - factors of importance for correct interpretation of results.
    Hartwig TS; Ambye L; Werge L; Weiergang MK; Nørgaard P; Sørensen S; Jørgensen FS
    Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():35-39. PubMed ID: 29804026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of combinatorial probe-anchor ligation-based sequencing as non-invasive prenatal test for trisomy at a central laboratory.
    Ma J; Wang Y; Wang W; Dong Y; Xu C; Zhou A; Xu Z; Wu Z; Tang X; Chen F; Yin Y; Wang W; Yan M; Zhang W; Mu F; Yang H
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):49-57. PubMed ID: 27363706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Review of Noninvasive Prenatal Testing: Experience from 551 Pregnancies with Noninvasive Prenatal Testing-Positive Results in a Tertiary Referral Center.
    Wu X; Li Y; Xie X; Su L; Cai M; Lin N; Du S; Xu L; Huang H
    J Mol Diagn; 2020 Dec; 22(12):1469-1475. PubMed ID: 33069877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of non-invasive prenatal testing for the screening of fetal chromosomal abnormalities in 12 085 cases].
    Wang L; Zhou C; Hu Y; Jin Y; Liu X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1069-1073. PubMed ID: 32924103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.